The Undertreatment of Anxiety: Overcoming the Confusion and Stigma

Journal of Psychosocial Nursing and Mental Health Services

Volumn 34, Issue 6, 1996, Pages 9-18

  Blair, D Thomas ^a   Ramones, Valerie A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT;

ADDICTION; ANXIETY DISORDER; ATTITUDE TO HEALTH; HEALTH PERSONNEL ATTITUDE; HUMAN; NURSING ASSESSMENT; PSYCHIATRIC NURSING; PSYCHOTHERAPY; REVIEW; SOCIAL PSYCHOLOGY;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; HUMANS; NURSING ASSESSMENT; PREJUDICE; PSYCHIATRIC NURSING; PSYCHOTHERAPY; SUBSTANCE-RELATED DISORDERS;

EID: 0030162404     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC; Author.
2. Apter, A., van Praag, H.M., Plutchik, R., Sevy, S., Korn, M., & Brown, S.L. (1990). Interrelationships among anxiety, aggression, impulsivity, and mood: A serotonergically linked cluster. Psychiatry Research, 32, 191-199.
3. Balter, M.B., Manheimer, D.I., & Mellinger, G.D. (1984). A cross-national comparison of antianxiety/sedative drug use. Current Medical Research and Opinion, 4, 5-20.
4. Barsky, A. (1988). Hidden reasons some patients visit doctors. Annals of Internal Medicine, 94, 492-498.
5. Barsky, A.J., Goodson, J.D., Lane, L.S., & Cleary, P.D. (1988). The amplification of somatic symptoms. Psychosomatic Medicine, 50, 510-519.
6. Bass, C.M. (1990). Somatization: Physical symptoms and psychological illness.(pp. 1-9). Oxford: Blackwell Scientific.
7. Beck, A.T., & Emery, G. (1985). Anxiety disorders and phobias. New York: Basic Books.
8. Beers, M., Avron, J., & Soumerai, S. (1988). Psychoactive medication use in intermediate care facility care residents. Journal of the American Medical Association, 260, 3016-3020.
9. Blair, D.T., & Hildreth, N.A. (1991). PTSD and the Vietnam veteran: The battle for treatment. Journal of Psychosocial Nursing and Mental Health Services, 29, 15-20.
10. Blair, D.T., & Ramones, V.A. (1994). Psychopharmacologic treatment of anxiety. Journal of Psychosocial Nursing and Mental Health Services, 32, 49-53.
11. Borus, J.F., Olendzki, M.C., & Kessler, L. (1985). The offset effect of mental health treatment on ambulatory medical care utilization and charges. Archives in General Psychiatry, 42, 573-580.
12. Brown, C., & Kirk, K. (1984). PRN drug utilization in long term care facilities. Hospital Pharmacies, 19, 692-696.
13. Busch, F.N., & Could, E. (1993). Treatment by a psychotherapist and psychopharmacologist: Transference and countertransference issues. Hospital and Community Psychiatry, 44, 772-774.
14. Cohen, F.L. (1980). Post surgical pain relief: Patients' status and purses' medication choices. Pain, 9, 265-274.
15. Craven, J.L., Voore, P.M., & Voineskos, G. (1987). PRN medications for psychiatric patients. Canadian Journal of Psychiatry, 32, 199-203.
16. Csernansky, J.G., Maddock R.J., & Hollister L.E. (1985). Pharmacologic treatment of aggression. Hospital Formulary, 2, 1091-1104.
17. Dubovsky, S.L. (1990). Generalized anxiety disorder: New concepts and psychopharmacologic therapies. Journal of Clinical Psychiatry, 51, 3-10.
18. Eison, A.S., & Temple, D.L. (1986). Buspirone: Review of its pharmacology and current perspectives on its mechanism of action. American Journal of Medicine, 80(3B, Suppl), 1-9.
19. Federici, C.M., & Tommasini, N.R. (1992). The assessment and management of panic disorder. Nurse Practitioner, 17, 20-25.
20. Fishel, A.H., Ferreiro, B.W., Rynerson, B.C., Nickell, M., Jackson, B., & Hannan, B.D. (1994). As needed psychotropic medications: Prevalence, indications and results. Journal of Psychosocial Nursing and Mental Health Services, 32, 27-32.
21. Fontaine, R., Chouinard, G., Annable, L., & Young, T. (1984). Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry, 141, 848-852.
22. Fothergill-Bourbonnais, F., & Wilson-Barnett, J. (1992). A comparative study of intensive therapy unit and hospice nurses' knowledge on pain management. Journal of Advanced Nursing, 17, 362-372.
23. Fox, L. (1982). Pain management in the terminally ill cancer patient. Military Medicine, 147, 455-460.
24. Freedman, A.M. (1986). Psychopharmacology and psychotherapy in the treatment of anxiety. In: A.M. Freedman (Ed), Current psychiatric therapies. New York: Grune and Stratton.
25. Friedman, M.J. (1990). Interrelationships between biological mechanisms and pharmacotherapy of post traumatic stress disorder. In W. Wolf, & J. Mosnain (Eds.), Post traumatic stress disorder: Etiology, phenomenology and treatment. Washington, DC: American Psychiatric Press.
26. Fulop, G., Stram, J.J., Vita, J., Lyons, J.S., & Hammer, J.S. (1987). Impact of psychiatric comorbidity on length of hospital stay in medical-surgical patients, a preliminary report. American Journal of Psychiatry, 144, 878-882.
27. Golombok, S., Higgitt, A., Fonagy, P., Dodds, S., Saper, J., & Lader, M. (1987). A follow-up study of patients treated for benzodiazepine dependence. British Journal of Medical Psychology, 60, 141-149.
28. Griffiths, R.R., & Sannerud, C.A. (1987). Abuse and dependence on benzodiazepines and other anxiolytics. In: H.Y. Meltzer (Ed.), Psychopharmacology: The third generation in progress. New York: Raven Press.
29. Hamilton, M. (1983). The clinical distinction between anxiety and depression. British Journal of Clinical Pharmacology, 15, 1655-1695.
30. Holder, H.D., & Those, J.O. (1987). Changes in health care costs and utilization associated with mental health treatment. Hospital and Community Psychiatry, 38, 1070-1075.
31. Hyman, S.E., & Cassem, N.H. (1989). Managing the person with major psychiatric illness. In: E. Rubenstein, D.D. Federmann (Eds.), Sci Am Med., 13, 1-18.
32. Insel, T.R., Ninan, P.T., & Aloy, J. (1984). A benzodiazepine receptor mediated model of anxiety. Archives in General Psychiatry, 41, 741-750.
33. Kaplan, C., Lipkin, M.J., & Gordon, G.H. (1988). Somatization in primary care: Patients with unexplained and vexing medical complaints. Journal of General Internal Medicine, 3, 177-190.
34. Katon, W., Berg, A.O., Robins, A.J., & Risse, S. (1986). Depression - medical utilization and somatization. Western Journal of Medicine, 144, 564-568.
35. Katon, W., Kleinman, A., & Rosen, G. (1982). Depression and somatization: A review, part I. American Journal of Medicine, 72, 127-135
36. Katon, W., Lin, E., VonKorff, M., Russo, J., Lipscomb, P., & Bush, T. (1991). Somatization: A spectrum of severity. American Journal of Psychiatry, 148, 9934-9940.
37. Lader, M., & Lawson, C. (1987). Sleep studies and rebound insomnia: Methodological problems, laboratory findings and clinical implications. Clinical Neuropharmacology, 10, 291-312.
38. Lander, J. (]990). Fallacies and phobias about addiction and pain. Journal of Addiction, 85, 803-809.
39. McCaffery, M., & Vourakis, C. (1992). Assessment and relief of pain in chemically dependent patients. Orthopaedic Nursing, 11, 13-27.
40. McEvoy, G.K. (1992). American hospital formulary service, drug information. Bethesda, MD: American Society of Hospital Pharmacists.
41. McLaren, S., Brown, F.W., & Taylor, P.J. (1990). Psychotropic medication given as required. British Journal of Psychiatry, 156, 732-735.
42. McMillan, S., Williams, F., Chatfield, R., & Camp, L.D. (1988). A validity and reliability study of two tools for assessing and managing cancer pain. Oncology Nursing Forum, 15, 735-741.
43. Mellinger, G.D., Balter, M.B., & Uhlenhuth, E.H. (1984). Prevention and correlates of long-term regular use of anxiolytics. Journal of the American Medical Association, 251, 375-379.
44. Morgan, J. (1985). American opiophobia: Customary under-utilization of opioid analgesics. Advances in Alcohol and Substance Abuse, 5, 163-173.
45. Mumford, E., Schlesinger, H.J., & Glass, G.V. (1984). A new look at evidence about reduced cost of medical utilization following mental health treatment. American Journal of Psychiatry, 141,1145-1158.
46. Oswald, I. (1986). Drugs for poor sleepers. British Medical Journal, 292, 715-717.
47. Paul, S.M. (1988). Anxiety and depression: A common neurobiological substrate. Journal of Clinical Psychiatry, 49(Suppl 10), 13-16.
48. Pertursson, H., & Lader, M. (1984). Dependence on tranquilizers. London: Oxford University Press.
49. Perry, S., & Heidrich, G. (1986). Management of pain during debridement in a survey of U. S. bum units. Pain, 13, 267-280.
50. Priest, R.G. (1980). The benzodiazepines: Today and tomorrow. Lancaster, PA: MPP Press.
51. Rankin, M.S., & Snider, B. (1984). Nurses perceptions of cancer patients' pain. Cancer Nursing, 7, 149-155.
52. Ratey, J., Sovner, R., Parks, A., & Rogentine, K. (1991). Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple-baseline, placebo lead-in study. Journal of Clinical Psychiatry, 52, 159-162.
53. Richens, A., & Griffiths, A.N. (1985). Pharmacokinetic and pharmacodynamic relationships with benzodiazepines. In: S.D. Iversen (Ed), Recent advances and future prospects. New York: Oxford University Press.
54. Rickels, K., & Schweizer, E. (1990). The clinical course and long term management of generalized anxiety disorder. Journal of Clinical Psychopharmacology, 51, 101-110.
55. Roberts, S.J. (1994). Somatization in primary care. Nurse Practitioner, 5, 47-56.
56. Roth, M. (1989). Anxiety disorders and the use and abuse of drugs. Journal of Clinical Psychiatry, 50, 30-35.
57. Seers, K. (1987). Pain, anxiety and recovery in patients under going surgery. Unpublished doctoral thesis. University of London, King's College, London.
58. Slack, J., & Faut-Callahan, M. (1991). Pain management. Nursing Clinics of North America, 26(2), 463-476.
59. Smith, G.R., Monson, R.A, & Ray, D.C. (1986). Patients with multiple unexplained symptoms - their characteristics, functional health and health care utilization. Archives of Internal Medicine, 146, 69-72.
60. Snaith, R.P. (1984). Benzodiazepines on trial. British Medical Journal, 288, 1379-1382.
61. Sussman, N., & Chou, J.C. (1988). Current issues in benzodiazopine use for anxiety disorders. Psychiatric Annals, 18, 139-145.
62. Swinson, R.P., Pecknold, J.C., & Kirby. M.E. (1987). Benzodiazepine dependence. Journal of Affective Disorders, 13, 109-118.
63. Taylor, F.K. (1989). The damnation of benzodiazepines. British Journal of Psychiatry, 154, 697-704.
64. Tollefson, G.D. (1991). Sorting out anxiety and depression. Physicians Assistant, 5, 22-34
65. Trewin, V.F., Pearce, V., & Veitch, G.B. (1986). Elderly patients at risk. British Journal of Pharmaceutical Practice, 8, 359-363.
66. Tyrer, P., & Murphy, S. (1987). The place of benzodiazepines in psychiatric practice. British Journal of Psychiatry, 151, 719-723.
67. van der Kolk, B.A. (1988). The biological response to trauma. In F. Ochberg (Ed.), Post-traumatic therapy and victims of violence. New York: Brunner/Mazel.
68. Watt-Watson, J. (1987). Nurses' knowledge of pain issues: A survey. Journal of Pain and Symptom Management, 2, 207-211.
69. Weissman, M., & Merikangas, K.R. (1986). The epidemiology of anxiety disorders: An update. Journal of Clinical Psychopharmacology, 46(Suppl 6),11-17.
70. Weissman, M.M. (1988a). Anxiety and alcoholism. Journal of Clinical Psychiatry, 49 (Suppl 10), 17-19.
71. Weissman, M.M. (1988b). The epidemiology of anxiety disorders: Rates, risks and familial patterns. Journal of Psychiatric Research, 22(Suppl 1), 99-114.
72. Wise, M.G., & Taylor, S.E. (1990). Anxiety and mood disorders in medically ill patients. Journal of Clinical Psychiatry, 51(Suppl 1), 27-31.